Workflow
neuroplasticity
icon
Search documents
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join Fireside Chat at BTIG Virtual Biotech Conference July 29 - 30, 2025
Prnewswire· 2025-07-29 12:03
Company Overview - NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for central nervous system disorders, including suicidal bipolar depression, chronic pain, and PTSD [4] - The company is developing NRX-101, which has been designated as an FDA Breakthrough Therapy for suicidal treatment-resistant bipolar depression, with plans to file a New Drug Application (NDA) for Accelerated Approval [4] Recent Developments - NRx Pharmaceuticals has filed an Abbreviated New Drug Application (ANDA) for NRX-100, a preservative-free IV ketamine, for currently approved indications [5] - The company has initiated an NDA filing for NRX-100 for the treatment of suicidal depression, based on clinical trial results and new data from French health authorities [5] - NRx has received Fast Track Designation from the US FDA for the development of NRX-100 to treat patients with acute suicidality and has filed a patent for this novel formulation [5] Events and Collaborations - The CEO and Chairman of NRx Pharmaceuticals will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on July 29-30, 2025, discussing neuroplasticity in CNS disorder treatments [1][2] - The discussion will include insights from Prof. Samuel Wilkinson, a pioneer in the understanding of ketamine and other neuroplastic drugs for treating depression and PTSD [2] Subsidiary Information - HOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals, is establishing a network of interventional psychiatry clinics to provide ketamine and other therapies for suicidal depression and related disorders [6]
BECOMING UNBREAKABLE HOW STRENGTHENING THE BODY STRENGTHENS THE MIND | Susanne Meish | TEDxEDHECNice
TEDx Talks· 2025-06-13 15:24
Good evening everyone. Have you ever thought about how your body will age. Somewhere between the age of 30 and 40, we start losing muscle mass at a rate of about 1% each year.That's normal. It's called sarcopenia. We get slower. We get more limited. and we get vulnerable to diseases.On top of these physical challenges, we also have mental and psychological challenges. Anxiety and depression are on the rise and even our teenagers are now stressed. So, what if there was one habit, one practice that you can ad ...